Algorithm of Management of Patients With Parotid Gland Tumors
Keywords:
neoplasms of the salivary glands, parotid salivary gland, diagnosis, epidemiology, multispiral computed tomography, magnetic resonance imaging, pathohistological examination, radiomic analysisAbstract
Neoplasms of the salivary glands are benign in most cases and in up to 80% of cases are localized in the parotid salivary gland (PSG). The features of the PSG structure, as well as the anatomical area in which the gland is located, and adjacent structures largely determine the high requirements for a set of diagnostic measures and surgical treatment tactics. The article is devoted to the analysis of the effectiveness of the proposed scheme of diagnostic and therapeutic measures for PSG neoplasms, which includes the results of radiomic analysis of MRI and CBCT, ultrasound of the area of interest with the identification of characteristic signs of nosological forms.
References
1. Iordanishvili A.K., Lobeyko V.V. Prevalence of salivary gland diseases in adults at different age periods // Clinical gerontology. 2014. – №20 (11-12). – Pp. 14-19.
2. Kuzmina E.V., Sotnikova M.V., Borovoy V.N., Nakonechny D.A. Problems of diagnosis of neoplasms of salivary glands. – Clinical dentistry. – 2023; 26 (3): 60-69.
3. Tarakanova O.V., Slavnova E.N. Cytological diagnosis of salivary gland tumors. Oncology. P.A. Herzen Magazine. 2022;11(5):78 88.
4. Shomurodov K.E., Latipova D.I., Alimdzhanova M.S. The prevalence of parotid salivary gland neoplasms and key aspects of their diagnosis. Integrative dentistry and maxillofacial surgery. 2024;3(3):65-71.
5. Shumkova E.N., Balapanova A.Kh., Alsherieva U.A., Iskakov A.J. Clinical and morphological aspects of salivary gland tumors. — Bulletin of Science and Education. — 2020; 14—1 (92): 74-76.
6. Abbate, V.; Orabona, G.D.A.; Barone, S.; Troise, S.; Bonavolontà, P.; Pacella, D.; Iaconetta, G.; Califano, L. Relevance of Inflammatory Biomarkers in Salivary Gland Cancers Management. Eurasian J. Med. Oncol. 2021, 5, 311-317.
7. Alsanie I, Rajab S, Cottom H, et al. Distribution and Frequency of Salivary Gland Tumours: An International Multicenter Study. Head Neck Pathol. 2022;16(4):1043-1054.
8. Atamaniuk V, Chen J, Obrzut M, et al. High-frequency shear wave MR elastography of parotid glands: custom driver design and preliminary results. Sci Rep. 2024;14(1):24496. Published 2024 Oct 18.
9. Cheng, G.; Liu, F.; Niu, X.; Fang, Q. Role of the pretreatment neutrophil-to-lymphocyte ratio in the survival of primary parotid cancer patients. Cancer Manag. Res. 2019, 11, 2281–2286.
10. Damar, M.; Dinç, A.E.; Erdem, D.; Aydil, U.; Kizil, Y.; Eravcı, F.C.; Bişkin, S.; Şevik Eliçora, S.; Işik, H. Pretreatment Neutrophil-Lymphocyte Ratio in Salivary Gland Tumors Is Associated with Malignancy. Otolaryngol. Head Neck Surg. 2016, 155, 988-996.
11. Ghaderi, Hamid, Kruger, Estie, Ahmadvand, Simin, Mohammadi, Yousef, Khademi, Bijan, Ghaderi, Abbas, Epidemiological Profile of Salivary Gland Tumors in Southern Iranian Population: A Retrospective Study of 405 Cases, Journal of Cancer Epidemiology, 2023, 8844535, 11 pages, 2023.
12. Nardone, V.; Reginelli, A.; Grassi, R.; Boldrini, L.; Vacca, G.; D’Ippolito, E.; Annunziata, S.; Farchione, A.; Belfiore, M.P.; Desideri, I.; et al. Delta radiomics: A systematic review. Radiol. Med. 2021, 126, 1571–1583.
13. Peravali RK, Bhat HH, Upadya VH, Agarwal A, Naag S. Salivary gland tumors: a diagnostic dilemma!. J Maxillofac Oral Surg. 2015;14(Suppl 1):438-442.
14. Rossi ED, Faquin WC, Baloch Z, Barkan GA, Foschini MP, Pusztaszeri M, Vielh P, Kurtycz DFI. The Milan System for Reporting Salivary Gland Cytopathology: analysis and suggestions of initial survey. Cancer Cytopathol. 2017;125(10):757-766.
